Jason Lettmann - 14 Feb 2024 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Peter Garcia, by power of attorney
Issuer symbol
ALXO
Transactions as of
14 Feb 2024
Net transactions value
$0
Form type
4
Filing time
16 Feb 2024, 18:03:55 UTC
Previous filing
12 Sep 2023
Next filing
18 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Award $0 +60,000 +56% $0.000000 167,220 14 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option Award $0 +190,000 $0.000000 190,000 14 Feb 2024 Common Stock 190,000 $15.84 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.
F2 Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.